Cargando…
Development and validation of a non-invasive biomarker-based model to identify endoscopic recurrences of Crohn’s disease
BACKGROUND: Endoscopic recurrence is common in postoperative patients with Crohn’s disease (CD). Monitoring endoscopic recurrence is important for selecting an appropriate treatment to prevent the development of postoperative disease. The aim of this study was to develop and validate a diagnostic mo...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984852/ https://www.ncbi.nlm.nih.gov/pubmed/35399190 http://dx.doi.org/10.1177/17562848221089096 |
_version_ | 1784682270598103040 |
---|---|
author | Zhou, Gaoshi Chen, Rirong Jiang, Yueyun Li, Li Zheng, Jieqi Li, Chao Zhang, Shenghong Chen, Minhu |
author_facet | Zhou, Gaoshi Chen, Rirong Jiang, Yueyun Li, Li Zheng, Jieqi Li, Chao Zhang, Shenghong Chen, Minhu |
author_sort | Zhou, Gaoshi |
collection | PubMed |
description | BACKGROUND: Endoscopic recurrence is common in postoperative patients with Crohn’s disease (CD). Monitoring endoscopic recurrence is important for selecting an appropriate treatment to prevent the development of postoperative disease. The aim of this study was to develop and validate a diagnostic model to identify endoscopic recurrence. METHODS: This was a retrospective cohort study recruiting postoperative CD patients who underwent endoscopy at the First Affiliated Hospital, Sun Yat-sen University from January 2016 to June 2020. Endoscopic recurrence was defined as Rutgeerts score > i1. Thirty non-invasive biomarkers, including C-reactive protein, erythrocyte sedimentation rate, vitamin D, complete blood count, and biochemical blood indices, were used as candidate predictors to build a multivariate logistic regression diagnostic model. The predictive ability of the diagnostic models was assessed by receiving the area under the characteristic curve (AUC) and calibration plots, and internal validation was performed by the bootstrap method. RESULTS: Two hundred and nineteen eligible patients were included in this study, and 135 (61.6%) patients had a postoperative endoscopic recurrence. The final diagnostic model included eight biomarkers with an AUC (95% confidence interval (CI)) of 0.796 (0.737–0.855) to identify endoscopic recurrence. The AUC, sensitivity, and specificity of this diagnostic model were 0.781 (0.780–0.782), 0.647 (0.643–0.651) and 0.811 (0.807–0.815), respectively, by internal validation. In addition, the diagnostic model exhibited good calibrability with calibration slope, calibration-in-the-large (‘mean calibration’) and Brier scores of 1.00, 0.00, and 0.175, respectively. CONCLUSION: This non-invasive biomarker-based diagnostic model has an excellent ability to identify endoscopic recurrence in patients with CD. Application of the model to clinical practice to monitor postoperative patients may be helpful for patient management. |
format | Online Article Text |
id | pubmed-8984852 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-89848522022-04-07 Development and validation of a non-invasive biomarker-based model to identify endoscopic recurrences of Crohn’s disease Zhou, Gaoshi Chen, Rirong Jiang, Yueyun Li, Li Zheng, Jieqi Li, Chao Zhang, Shenghong Chen, Minhu Therap Adv Gastroenterol Original Research BACKGROUND: Endoscopic recurrence is common in postoperative patients with Crohn’s disease (CD). Monitoring endoscopic recurrence is important for selecting an appropriate treatment to prevent the development of postoperative disease. The aim of this study was to develop and validate a diagnostic model to identify endoscopic recurrence. METHODS: This was a retrospective cohort study recruiting postoperative CD patients who underwent endoscopy at the First Affiliated Hospital, Sun Yat-sen University from January 2016 to June 2020. Endoscopic recurrence was defined as Rutgeerts score > i1. Thirty non-invasive biomarkers, including C-reactive protein, erythrocyte sedimentation rate, vitamin D, complete blood count, and biochemical blood indices, were used as candidate predictors to build a multivariate logistic regression diagnostic model. The predictive ability of the diagnostic models was assessed by receiving the area under the characteristic curve (AUC) and calibration plots, and internal validation was performed by the bootstrap method. RESULTS: Two hundred and nineteen eligible patients were included in this study, and 135 (61.6%) patients had a postoperative endoscopic recurrence. The final diagnostic model included eight biomarkers with an AUC (95% confidence interval (CI)) of 0.796 (0.737–0.855) to identify endoscopic recurrence. The AUC, sensitivity, and specificity of this diagnostic model were 0.781 (0.780–0.782), 0.647 (0.643–0.651) and 0.811 (0.807–0.815), respectively, by internal validation. In addition, the diagnostic model exhibited good calibrability with calibration slope, calibration-in-the-large (‘mean calibration’) and Brier scores of 1.00, 0.00, and 0.175, respectively. CONCLUSION: This non-invasive biomarker-based diagnostic model has an excellent ability to identify endoscopic recurrence in patients with CD. Application of the model to clinical practice to monitor postoperative patients may be helpful for patient management. SAGE Publications 2022-04-04 /pmc/articles/PMC8984852/ /pubmed/35399190 http://dx.doi.org/10.1177/17562848221089096 Text en © The Author(s), 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Research Zhou, Gaoshi Chen, Rirong Jiang, Yueyun Li, Li Zheng, Jieqi Li, Chao Zhang, Shenghong Chen, Minhu Development and validation of a non-invasive biomarker-based model to identify endoscopic recurrences of Crohn’s disease |
title | Development and validation of a non-invasive biomarker-based model to
identify endoscopic recurrences of Crohn’s disease |
title_full | Development and validation of a non-invasive biomarker-based model to
identify endoscopic recurrences of Crohn’s disease |
title_fullStr | Development and validation of a non-invasive biomarker-based model to
identify endoscopic recurrences of Crohn’s disease |
title_full_unstemmed | Development and validation of a non-invasive biomarker-based model to
identify endoscopic recurrences of Crohn’s disease |
title_short | Development and validation of a non-invasive biomarker-based model to
identify endoscopic recurrences of Crohn’s disease |
title_sort | development and validation of a non-invasive biomarker-based model to
identify endoscopic recurrences of crohn’s disease |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984852/ https://www.ncbi.nlm.nih.gov/pubmed/35399190 http://dx.doi.org/10.1177/17562848221089096 |
work_keys_str_mv | AT zhougaoshi developmentandvalidationofanoninvasivebiomarkerbasedmodeltoidentifyendoscopicrecurrencesofcrohnsdisease AT chenrirong developmentandvalidationofanoninvasivebiomarkerbasedmodeltoidentifyendoscopicrecurrencesofcrohnsdisease AT jiangyueyun developmentandvalidationofanoninvasivebiomarkerbasedmodeltoidentifyendoscopicrecurrencesofcrohnsdisease AT lili developmentandvalidationofanoninvasivebiomarkerbasedmodeltoidentifyendoscopicrecurrencesofcrohnsdisease AT zhengjieqi developmentandvalidationofanoninvasivebiomarkerbasedmodeltoidentifyendoscopicrecurrencesofcrohnsdisease AT lichao developmentandvalidationofanoninvasivebiomarkerbasedmodeltoidentifyendoscopicrecurrencesofcrohnsdisease AT zhangshenghong developmentandvalidationofanoninvasivebiomarkerbasedmodeltoidentifyendoscopicrecurrencesofcrohnsdisease AT chenminhu developmentandvalidationofanoninvasivebiomarkerbasedmodeltoidentifyendoscopicrecurrencesofcrohnsdisease |